Results 31 to 40 of about 9,865 (187)
Alternative approach to treating malignant glaucoma after trabeculectomy with unplanned zonulectomy
Clinical Ophthalmology, 2010 Naoki Ozeki1, Kenya Yuki1, Itaru Kimura1,21Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan, 2Department of Ophthalmology, Juntendo University Urayasu Hospital, Chiba, JapanPurpose: To report the role of Healon5TM injection ...
Naoki Ozeki, Kenya Yuki, Itaru Kimura
doaj
Mesna in Otologic Surgery: Efficacy and Safety—A Scoping Review
The Laryngoscope, EarlyView.PRISMA flow diagram indicating the process of systematic inclusion and exclusion of articles. ABSTRACT Objective Mesna (Sodium 2‐mercaptoethanesulfonate) is widely used as a mucolytic agent and uroprotective agent. Recently, its disulfide bond‐breaking property has been applied in otologic surgery to facilitate safer dissection of cholesteatoma and ...
Kevork H. Atamian +4 more
wiley +1 more source
Clinical Ophthalmology, 2018 Desirée Murray,1,2 Peter Shah2–5 1Department of Clinical Surgical Sciences, The University of the West Indies, St Augustine, Trinidad and Tobago, West Indies; 2Birmingham Institute for Glaucoma Research, Institute of Translational Medicine,
Murray D, Shah P
doaj
Clinical Ophthalmology, 2022 Mark J Gallardo,1– 3 Logan R Vincent,1 Matthew Porter2 1El Paso Eye Surgeons, El Paso, TX, USA; 2Department of Ophthalmology, Texas Tech University School of Medicine, Lubbock, TX, USA; 3Department of Ophthalmology, University of Texas Health Sciences ...
Gallardo MJ, Vincent LR, Porter M
doaj
PROTEOMICS, EarlyView.ABSTRACT Epithelial‐mesenchymal transition (EMT) is a fundamental, dynamic cellular process involved in embryonic development, metastasis, organ fibrosis, and tissue regeneration. To define the molecular landscape of secreted midbody remnants (MBRs) to the EMT process, a proteome analysis of MBRs released from Madin–Darby canine kidney (MDCK) cells and
Adnan Shafiq +6 more
wiley +1 more source
Migrasomes, Matrix‐Bound Nanovesicles, and More: Messengers in the Matrix
PROTEOMICS, EarlyView.ABSTRACT Extracellular vesicles (EVs) and particles (EPs) are diverse micro‐ and nanoparticles that circulate in bodily fluids and can attach to, or be deposited onto, the extracellular matrix (ECM) and other surfaces. To date, the nomenclature and classification of matrix‐bound or matrix‐associated EVs and EPs (MEVPs) have been unclear, largely due to
Anna V. Kolesov +3 more
wiley +1 more source
Infection and Drug Resistance, 2015 Patcharin Khamnuan,1,2 Wilaiwan Chongruksut,3 Kijja Jearwattanakanok,4 Jayanton Patumanond,5 Apichat Tantraworasin,3 1Clinical Epidemiology Program, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 2Department of Nursing, Phayao Hospital,
Khamnuan P +4 more
doaj
Precision Medical Sciences, EarlyView.Abstract ROS1‐rearranged lung adenocarcinoma is a rare subset of non‐small‐cell lung cancer, typically occurring in young never‐smokers. Its occurrence in very young men with a fluid‐dominant presentation is unusual and may lead to diagnostic pitfalls.
Thanh Thao Nguyen +4 more
wiley +1 more source
Corneal decompensation following filtering surgery with the Ex-PRESS® mini glaucoma shunt device
Clinical Ophthalmology, 2015 Naoki Tojo, Atsushi Hayashi, Akio Miyakoshi Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan Purpose: To report a case of corneal decompensation due to the Ex-PRESS® mini ...
Tojo N, Hayashi A, Miyakoshi A
doaj
Nature Inspired Delivery Vehicles for CRISPR‐Based Genome Editing
Small, EarlyView.The review highlights nature‐inspired nanocarriers for CRISPR delivery, emphasizing viral vectors, extracellular vesicles, liposomes, and lipid nanoparticles. It discusses their roles in improving specificity, minimizing immunogenicity, and overcoming barriers in genome editing. Recent advancements, challenges, and therapeutic applications are explored,
Elizabeth Maria Clarissa +4 more
wiley +1 more source